NASDAQ:MCRB | Free Cash Flow | Seres Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$16.36M$0.00-$16.36M
2025-12-31-$14.71M$29,000.00-$14.74M
2025-03-31$26.91M$34,000.00$26.88M82.23%
2024-12-31-$38.88M$90,000.00-$38.97M
2024-03-31-$35.24M$62,000.00-$35.3M
2023-12-31-$47.5M$877,000.00-$48.38M
2023-03-31-$76.58M$4.07M-$80.65M
2022-12-31-$52.89M$3.46M-$56.35M
2022-03-31-$66.45M$2.95M-$69.4M
2021-12-31-$51.86M$1.58M-$53.44M
2021-03-31-$29.5M$1.34M-$30.84M
2020-12-31-$17.93M$226,000.00-$18.15M
2020-03-31-$24.25M$71,000.00-$24.32M
2019-12-31-$14.05M$230,000.00-$14.28M
2019-03-31-$32.39M$306,000.00-$32.7M
2018-12-31$12.67M-$196,000.00$12.47M
2018-03-31-$26.76M$953,000.00-$27.72M
2017-12-31-$20.61M$685,000.00-$21.29M
2017-03-31-$25.65M$2.25M-$27.9M
2016-12-31-$20.81M$5.69M-$26.49M
2016-03-31$101.42M$3.4M$98.02M
2015-12-31-$11.57M$1.24M-$12.81M
2015-03-31-$8.34M$214,000.00-$8.55M
2014-12-31-$4.12M$374,000.00-$4.49M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$1.12M$252,000.00$865,000.0015.19%
2024-12-31-$148.61M$380,000.00-$148.99M-109550.74%
2023-12-31-$117.35M$7.98M-$125.33M
2022-12-31-$228.82M$9.82M-$238.64M
2021-12-31$6.69M$9.57M-$2.88M
2020-12-31-$93.61M$591,000.00-$94.2M
2019-12-31-$76.52M$1M-$77.52M
2018-12-31-$62.85M$1.94M-$64.79M
2017-12-31-$75.52M$4.68M-$80.2M
2016-12-31$43.92M$21.49M$22.43M
2015-12-31-$40.84M$4.36M-$45.21M
2014-12-31-$10.36M$1M-$11.36M
2013-12-31-$5.32M$174,000.00-$5.5M